uniQure Announces 2019 Financial Results and Highlights Recent Company Progress ~ Patient Dosing Nearly Completed in Phase III HOPE-B Trial of Etranacogene Dezaparvovecin Hemophilia B ~ ~ First Patient Procedure in Phase I/II Clinical Trial of AMT-130 in Huntington’s Disease...

ATN Reports Fourth Quarter and Full Year 2019 Results Continued growth in domestic and international telecom drives improved underlying operating resultsTelecom businesses well positioned to continue to deliver strong financial performance in 2020       ...